Who
Patrick John Finn
President and COO
Company insider
Files Form 4 as: President and COO, Twist Bioscience.
In numbers
- Trades disclosed
- 345
- Buys
- 0
- Sells
- 79
- Bought
- $0
- Sold
- $55.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Nov 2018
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $4.9M25,714 at $188.88 | filing |
| 21 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $563K4,046 at $139.07 | filing |
| 21 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $563K4,046 at $139.07 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $1.6M23,355 at $67.85 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $3.9M33,354 at $115.90 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.2M10,420 at $116.82 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —23,355 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.0M8,868 at $117.70 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $536K4,500 at $119.04 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.5M12,917 at $119.86 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $762K6,296 at $121.01 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $245K2,000 at $122.58 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist Bioscienceoption or derivative · Genomics & Gene Editing | SEC FORM 4 Code M | —23,355 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code M | $1.6M23,355 at $67.85 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $3.9M33,354 at $115.90 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.2M10,420 at $116.82 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.0M8,868 at $117.70 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $536K4,500 at $119.04 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $1.5M12,917 at $119.86 | filing |
| 18 Aug 2026filed 20 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $762K6,296 at $121.01 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Patrick John Finn; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.